CollPlant Biotechnologies (CLGN) Retained Earnings (2017 - 2026)

CollPlant Biotechnologies has reported Retained Earnings for 10 years, with the latest figure at -$127.9 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 11.44% year-over-year to -$127.9 million; the trailing twelve-month figure through Mar 2026 stood at -$127.9 million (down 11.44% YoY), and the FY2025 full-year result was -$124.8 million, down 10.14% from the prior year.
• Retained Earnings for Q1 2026 stood at -$127.9 million, down from -$124.8 million in the prior quarter.
• The five-year high for Retained Earnings was -$76.7 million in Q1 2022, with the low at -$127.9 million in Q1 2026.
• Historically, Retained Earnings has averaged -$102.3 million across 5 years, with a median of -$100.9 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings declined 23.61% — and 2023, when it fell 7.82%.
• CollPlant Biotechnologies' Retained Earnings stood at -$89.7 million in 2022, then declined by 7.82% to -$96.7 million in 2023, then decreased by 17.17% to -$113.4 million in 2024, then declined by 10.14% to -$124.8 million in 2025, then declined by 2.48% to -$127.9 million in 2026.
• The last three Retained Earnings figures came in at -$127.9 million (Q1 2026), -$124.8 million (Q4 2025), and -$121.6 million (Q3 2025), per Business Quant data.